Effect of intravitreal ranibizumab on serous retinal detachment in branch retinal vein occlusion

Emine Dogan,1 Ozkan Sever,2 Burcin Köklü Çakir,1 Erkan Celik1 1Department of Ophthalmology, Sakarya University Medical Education and Research Hospital, Sakarya, Turkey; 2Department of Ophthalmology, Namik Kemal University School of Medicine, Namik Kemal University, Teki...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Dogan E, Sever O, Köklü Çakir B, Celik E
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://doaj.org/article/f7078d45573945d2b78bfc515c250b47
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f7078d45573945d2b78bfc515c250b47
record_format dspace
spelling oai:doaj.org-article:f7078d45573945d2b78bfc515c250b472021-12-02T06:19:48ZEffect of intravitreal ranibizumab on serous retinal detachment in branch retinal vein occlusion1177-5483https://doaj.org/article/f7078d45573945d2b78bfc515c250b472018-08-01T00:00:00Zhttps://www.dovepress.com/effect-of-intravitreal-ranibizumab-on-serous-retinal-detachment-in-bra-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Emine Dogan,1 Ozkan Sever,2 Burcin Köklü Çakir,1 Erkan Celik1 1Department of Ophthalmology, Sakarya University Medical Education and Research Hospital, Sakarya, Turkey; 2Department of Ophthalmology, Namik Kemal University School of Medicine, Namik Kemal University, Tekirdag, Turkey Purpose: The aim of this study was to evaluate the effect of initial intravitreal ranibizumab injection on visual acuity (VA) and central macular thickness (CMT) for the treatment of macular edema (ME) with and without serous retinal detachment (SRD) secondary to branch retinal vein occlusion (BRVO). Materials and methods: Fifty-two BRVO eyes, treated with intravitreal ranibizumab injection for ME with and without SRD, were retrospectively reviewed. Patients were divided into two groups according to spectral domain optical coherence tomography (SD-OCT). The efficacy of intravitreal ranibizumab injection at first month was assessed by analyzing the change in best-corrected VA and reduction in CMT with SD-OCT. Results: There were 21 patients with SRD and 31 patients with only CME (no-SRD). CMT was significantly greater in the SRD group than in the CME group (451±62.2 µm vs 383.5±37.2 µm, respectively, P<0.05). After initial intravitreal ranibizumab injection, mean VA improved from 0.87±0.26 logarithm of the minimum angle of resolution (LogMAR) to 0.54±0.27 LogMAR (P<0.01) and CMT decreased from 451±62.2 µm to 379.3±58.6 µm (P<0.001) in the SRD group. In the no-SRD group, mean VA improved from 0.69±0.25 LogMAR to 0.44±0.25 LogMAR (P<0.001) and the CMT decreased from 383.5±37.2 µm to 337.7±39.4 µm (P<0.001) at the first month visit. Eyes with SRD revealed better anatomic results and greater reduction of CMT after intravitreal ranibizumab injection (P<0.01). Conclusion: VA and CMT can be improved by intravitreal ranibizumab injection in BRVO patients with and without SRD. However, more marked improvement in macular morphology was achieved in patients with SRD than those without SRD. Keywords: ranibizumab, vein occlusion, serous detachmentDogan ESever OKöklü Çakir BCelik EDove Medical PressarticleRanibizumabVein occlusionSerous detachmentOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 12, Pp 1465-1470 (2018)
institution DOAJ
collection DOAJ
language EN
topic Ranibizumab
Vein occlusion
Serous detachment
Ophthalmology
RE1-994
spellingShingle Ranibizumab
Vein occlusion
Serous detachment
Ophthalmology
RE1-994
Dogan E
Sever O
Köklü Çakir B
Celik E
Effect of intravitreal ranibizumab on serous retinal detachment in branch retinal vein occlusion
description Emine Dogan,1 Ozkan Sever,2 Burcin Köklü Çakir,1 Erkan Celik1 1Department of Ophthalmology, Sakarya University Medical Education and Research Hospital, Sakarya, Turkey; 2Department of Ophthalmology, Namik Kemal University School of Medicine, Namik Kemal University, Tekirdag, Turkey Purpose: The aim of this study was to evaluate the effect of initial intravitreal ranibizumab injection on visual acuity (VA) and central macular thickness (CMT) for the treatment of macular edema (ME) with and without serous retinal detachment (SRD) secondary to branch retinal vein occlusion (BRVO). Materials and methods: Fifty-two BRVO eyes, treated with intravitreal ranibizumab injection for ME with and without SRD, were retrospectively reviewed. Patients were divided into two groups according to spectral domain optical coherence tomography (SD-OCT). The efficacy of intravitreal ranibizumab injection at first month was assessed by analyzing the change in best-corrected VA and reduction in CMT with SD-OCT. Results: There were 21 patients with SRD and 31 patients with only CME (no-SRD). CMT was significantly greater in the SRD group than in the CME group (451±62.2 µm vs 383.5±37.2 µm, respectively, P<0.05). After initial intravitreal ranibizumab injection, mean VA improved from 0.87±0.26 logarithm of the minimum angle of resolution (LogMAR) to 0.54±0.27 LogMAR (P<0.01) and CMT decreased from 451±62.2 µm to 379.3±58.6 µm (P<0.001) in the SRD group. In the no-SRD group, mean VA improved from 0.69±0.25 LogMAR to 0.44±0.25 LogMAR (P<0.001) and the CMT decreased from 383.5±37.2 µm to 337.7±39.4 µm (P<0.001) at the first month visit. Eyes with SRD revealed better anatomic results and greater reduction of CMT after intravitreal ranibizumab injection (P<0.01). Conclusion: VA and CMT can be improved by intravitreal ranibizumab injection in BRVO patients with and without SRD. However, more marked improvement in macular morphology was achieved in patients with SRD than those without SRD. Keywords: ranibizumab, vein occlusion, serous detachment
format article
author Dogan E
Sever O
Köklü Çakir B
Celik E
author_facet Dogan E
Sever O
Köklü Çakir B
Celik E
author_sort Dogan E
title Effect of intravitreal ranibizumab on serous retinal detachment in branch retinal vein occlusion
title_short Effect of intravitreal ranibizumab on serous retinal detachment in branch retinal vein occlusion
title_full Effect of intravitreal ranibizumab on serous retinal detachment in branch retinal vein occlusion
title_fullStr Effect of intravitreal ranibizumab on serous retinal detachment in branch retinal vein occlusion
title_full_unstemmed Effect of intravitreal ranibizumab on serous retinal detachment in branch retinal vein occlusion
title_sort effect of intravitreal ranibizumab on serous retinal detachment in branch retinal vein occlusion
publisher Dove Medical Press
publishDate 2018
url https://doaj.org/article/f7078d45573945d2b78bfc515c250b47
work_keys_str_mv AT dogane effectofintravitrealranibizumabonserousretinaldetachmentinbranchretinalveinocclusion
AT severo effectofintravitrealranibizumabonserousretinaldetachmentinbranchretinalveinocclusion
AT koklucakirb effectofintravitrealranibizumabonserousretinaldetachmentinbranchretinalveinocclusion
AT celike effectofintravitrealranibizumabonserousretinaldetachmentinbranchretinalveinocclusion
_version_ 1718399969708212224